Back to Pathway Library


Cancer Treatment

Cancer accounts for almost 20M new diagnoses and 10M deaths. As treatments have been improved during last decade, the need to closely monitor adverse effects of these therapeutics is more and more recognized.

What does Hilly do?

  1. Contacts patients periodically;
  2. Evaluates the presence of warning signs;
  3. Warns health teams if symptoms suggest chemotherapy and/or immunotherapy complications.

Key advantages

  • Improve patient safety and experience;
  • Reduce the time spent on repetitive tasks;
  • Improve patient stratification
  • Focus on severe illnesses related symptoms;
  • Faster detection of severe symptoms;
  • Reduce pressure on emergency departments and inpatient beds;
  • Optimize the use of resources, reduce costs and increase capacity.


  • Abdel-Wahab N, Alshawa A, Suarez-Almazor ME. Adverse Events in Cancer Immunotherapy. Adv Exp Med Biol. 2017;995:155-174. doi:10.1007/978-3-319-53156-4_8
  • Ingrand I, Defossez G, Lafay-Chebassier C, et al. Serious adverse effects occurring after chemotherapy: A general cancer registry-based incidence survey. Br J Clin Pharmacol. 2020;86(4):711-722. doi:10.1111/bcp.14159
  • Lipitz-Snyderman A, Pfister D, Classen D, et al. Preventable and mitigable adverse events in cancer care: Measuring risk and harm across the continuum. Cancer. 2017;123(23):4728-4736. doi:10.1002/cncr.30916

Move towards Patient-Centered care with UpHill

Talk to Sales